Viewing Study NCT00288899



Ignite Creation Date: 2024-05-05 @ 4:38 PM
Last Modification Date: 2024-10-26 @ 9:22 AM
Study NCT ID: NCT00288899
Status: COMPLETED
Last Update Posted: 2017-06-06
First Post: 2006-02-06

Brief Title: Benefits of Repeat Back Protocols Within A Computer-Based Informed Consent Program
Sponsor: VA Office of Research and Development
Organization: VA Office of Research and Development

Study Overview

Official Title: Benefits of Repeat Back Protocols Within A Computer-Based Informed Consent Program
Status: COMPLETED
Status Verified Date: 2017-06
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This is a VA Merit Review Study involving 7 VA medical centers participating in a parallel group randomized trial comparing repeat back versus standard electronic consent for 4 common elective surgical procedures total hip arthroplasty carotid endarterectomy laparoscopic cholecystectomy and radical prostatectomy Baseline covariates include health status SF-12 reading ability REALM and demographics Primary outcomes are patient comprehension of the informed consent patient satisfaction with the informed consent and decision making processes patient satisfaction with care anxiety STAI and provider assessment of the repeat back process In addition we are electronically capturing data detailing time spent in each phase of the consent process including repeat back
Detailed Description: Background Informed consent for surgical procedures is critical to patient care in the VA and in other health care settings Many studies document limitations in current methods of obtaining informed consent These limitations include poor patient comprehension inadequate time for discussion poor documentation of consent and heightening of patient anxiety regarding surgery In hopes of addressing these shortcomings both the NQF and AHRQ have recommended that repeat back protocols be added to informed consent methodologies The VA has opted to address the informed consent issue by computerization of the informed consent process utilizing the iMedConsent program This latter program is fully integrated with the computerized patient record system CPRS includes extensive patient education materials standardizes risk information and guides the clinician through the consent process The iMedConsent program is being disseminated via an ongoing national rollout Despite its apparent advantages the current iMedConsent platform does not incorporate any methodology to support repeat back Dialog Medical the iMedConsent vendor has recently developed a new module that can enhance the current version of the program by supporting repeat back protocols

Objectives We hypothesize that use of the enhanced iMedConsent program with repeat back will improve the surgical patients comprehension about the surgical technique treatment alternatives and risks and benefits of the proposed surgery in comparison with the standard iMedConsent program We believe that this enhanced program will also lead to better patient satisfaction with the consent process decision making and the health care received less anxiety about the operation and that this program will be acceptable to surgical providers and might lead to better clinical outcomes

Methods To address these hypotheses we are conducting a multi-site 7 VA Medical Centers randomized trial comparing the use of the standard and enhanced iMedConsent program We will enroll 600 subjects who are scheduled for elective surgery Subjects will be individually randomized to the standard or enhanced versions of the iMedConsent program The surgical procedures to be studied include carotid endarterectomy total hip arthroplasty radical prostatectomy and laparoscopic cholecystectomy The study will be linked to the National Surgical Quality Improvement Program data which will provide baseline data on patient characteristics intraoperative variables eg operation type time anesthesia method etc and the data on 30 day surgical outcomes We will assess endpoints including patient comprehension patient satisfaction with the consent process patient anxiety providers acceptance of the informed consent process and patient satisfaction with health care and with decision making using validated self-report survey instruments

Findings We are currently in the final phase of data analysis The final study report will be submitted within the next several weeks to HSRD

Status Study recruitment and enrollment began in August 2006 and ended June 30 2008 575 study subjects were randomized with 502 study subjects completing the study 214 surgical providers participated and 192 completed provider questionnaires We continue with final data analysis phase of the study Manuscripts are being written with final HSRD report due within the next several weeks

Impact The results of this study will have important implications for improving the consent process within the VA and beyond

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None